Sigknow Biomedical Co., Ltd. – Trademark Portfolio
Entity Type: 03
Sigknow Biomedical Co., Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EZYPRO, SIGKNOW, and JUSTWIPE. The owner is based in Taipei City 105.
Songshan Dist.
6F., No. 760, Sec. 4, Bade Rd.
Taipei City 105 , TW
Showing of trademarks Trademarks
Trademark Classifications
Sigknow Biomedical Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Sigknow Biomedical Co., Ltd. have?
Sigknow Biomedical Co., Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Sigknow Biomedical Co., Ltd. file in?
Sigknow Biomedical Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Sigknow Biomedical Co., Ltd.'s most well-known trademarks?
Sigknow Biomedical Co., Ltd.'s registered trademark portfolio includes well-known marks such as EZYPRO, SIGKNOW, and JUSTWIPE. These are among 4 currently registered trademarks in the portfolio.
What is Sigknow Biomedical Co., Ltd.'s trademark registration success rate?
Sigknow Biomedical Co., Ltd. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.